The Use of Contrast-Enhanced Ultrasound in Genituourinary Imaging: Technical and Clinical Considerations
- PMID: 41136107
- DOI: 10.1016/j.rcl.2025.04.009
The Use of Contrast-Enhanced Ultrasound in Genituourinary Imaging: Technical and Clinical Considerations
Abstract
Ultrasound (US) has many known advantages, including lack of ionizing radiation, low operating cost, and an unmatched safety profile. The development of contrast-enhanced US (CEUS) has proven to be a useful alternative or adjunct in the assessment of multiple organ system pathology, including genitourinary (GU), gastrointestinal, and pulmonary applications. CEUS offers several advantages over other contrast-enhanced modalities, including real-time enhancement kinetics, decreased contrast reactions, and lack of renal toxicity. CEUS is especially useful in assessment of GU pathology, where it can be used intravascularly as well as intraluminally within the collecting system to augment the evaluation of multiple GU pathologies.
Keywords: CEUS; Contrast-enhanced ultrasound; Genitourinary imaging; Microbubbles; Renal; Scrotal.
Published by Elsevier Inc.
Conflict of interest statement
Disclosures C.E. Calderone: None. M.E. Lockhart: Book royalties, Elsevier. Book royalties, JayPee Brothers Medical Publishers. Deputy Editor, Journal of Ultrasound in Medicine. Chair, American Board of Radiology Ultrasound Certifying Committee. Chair, AIUM Future Fund Research Committee. Executive Board, Society of Radiologists in Ultrasound. Member, US FDA Medical Devices Committee. D.T. Fetzer: Research agreements, GE HealthCare, Philips Ultrasound, Inc. and Siemens Healthineers. Consultant, GE Healthcare; Philips Ultrasound, Inc. Advisory Board, Bracco Diagnostics. Speakers Bureau, GE HealthCare; Siemens Healthineers.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
